About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD40.00
- USD41.99
- USD38.25
- USD52.26
- 39.60%
- 24M
- 4.26k
- 18.12k
- 113M
- 4.01
- 483.60%
Stock News
3 hours ago
American hires industry veteran to lead commercial team as profits trail rivals
CNBC
3 hours ago
Smaller is better for Honeywell, as profit outlook is raised ahead of Solstice spinoff
MarketWatch
4 hours ago
Most potential homebuyers expect mortgage rates to drop. That's why they're waiting
CNBC
4 hours ago
American Airlines' fourth quarter forecast tops estimates
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
